Tumor Burden < Tumor Cells, Cultured < Tumor Lysis Syndrome

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by Tumor Cells, Cultured

Number of relevant bibliographic references: 12.

Ident.	Authors (with country if any)	Title
000788 (2019)	Hind Hashwah ; Katrin Bertram ; Kristin Stirm ; Anna Stelling ; Cheuk-Ting Wu ; Sabrina Kasser ; Markus G. Manz ; Alexandre P. Theocharides ; Alexandar Tzankov ; Anne Müller	The IL‐6 signaling complex is a critical driver, negative prognostic factor, and therapeutic target in diffuse large B‐cell lymphoma
000B00 (2019)	Yueh-Shan Weng [Taïwan] ; Hong-Yu Tseng [Taïwan] ; Yen-An Chen [Taïwan] ; Pei-Chun Shen [Taïwan] ; Aushia Tanzih Al Haq [Taïwan] ; Li-Mei Chen [Taïwan] ; Yi-Chung Tung [Taïwan] ; Hsin-Ling Hsu [Taïwan]	MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
000C66 (2019)	Rosalie M. Sterner [États-Unis] ; Reona Sakemura ; Michelle J. Cox ; Nan Yang ; Roman H. Khadka ; Cynthia L. Forsman ; Michael J. Hansen ; Fang Jin ; Katayoun Ayasoufi ; Mehrdad Hefazi ; Kendall J. Schick ; Denise K. Walters ; Omar Ahmed [États-Unis] ; Dale Chappell [États-Unis] ; Tarek Sahmoud [États-Unis] ; Cameron Durrant [États-Unis] ; Wendy K. Nevala ; Mrinal M. Patnaik ; Larry R. Pease ; Karen E. Hedin ; Neil E. Kay ; Aaron J. Johnson ; Saad S. Kenderian	GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts.
001356 (2018)	Dong Wang [République populaire de Chine] ; Jiahui Xu [République populaire de Chine] ; Bingjie Liu [République populaire de Chine] ; Xueyan He [République populaire de Chine] ; Lei Zhou [République populaire de Chine] ; Xin Hu [République populaire de Chine] ; Feng Qiao [République populaire de Chine] ; Anli Zhang [République populaire de Chine] ; Xiaojun Xu [République populaire de Chine] ; Huafeng Zhang [République populaire de Chine] ; Max S. Wicha [États-Unis] ; Lixing Zhang [République populaire de Chine] ; Zhi-Ming Shao [République populaire de Chine] ; Suling Liu [République populaire de Chine]	IL6 blockade potentiates the anti-tumor effects of γ-secretase inhibitors in Notch3-expressing breast cancer.
001613 (2017)	Ximena Camacho ; Camila Longo Machado ; Maria Fernanda García ; Marcelo Fernández ; Natalia Oddone ; Juan Benech ; Juan Pablo Gambini ; Hugo Cerecetto ; Roger Chammas [Brésil] ; Pablo Cabral ; Eloisa Riva	Tocilizumab Labeling with 99mTechnetium via HYNIC as a Molecular Diagnostic Agent for Multiple Myeloma.
001727 (2017)	Jinghua Jiang [République populaire de Chine] ; Fei Ye [République populaire de Chine] ; Xue Yang [République populaire de Chine] ; Chen Zong [République populaire de Chine] ; Lu Gao [République populaire de Chine] ; Yang Yang [République populaire de Chine] ; Qiudong Zhao [République populaire de Chine] ; Zhipeng Han [République populaire de Chine] ; Lixin Wei [République populaire de Chine]	Peri-tumor associated fibroblasts promote intrahepatic metastasis of hepatocellular carcinoma by recruiting cancer stem cells.
001C43 (2016)	Feng-Ting Liu [République populaire de Chine] ; Li Jia [Royaume-Uni] ; Ping Wang [République populaire de Chine] ; Timothy Farren [Royaume-Uni] ; Hong Li [Royaume-Uni] ; Xishan Hao [République populaire de Chine] ; Samir G. Agrawal [Royaume-Uni]	CD126 and Targeted Therapy with Tocilizumab in Chronic Lymphocytic Leukemia.
001E88 (2015)	Hiroki Goto [Japon] ; Eriko Kudo ; Ryusho Kariya ; Manabu Taura ; Harutaka Katano ; Seiji Okada	Targeting VEGF and interleukin-6 for controlling malignant effusion of primary effusion lymphoma.
002286 (2014)	Shanshan Wan [États-Unis] ; Ende Zhao [États-Unis] ; Ilona Kryczek [États-Unis] ; Linda Vatan [États-Unis] ; Anna Sadovskaya [États-Unis] ; Gregory Ludema [États-Unis] ; Diane M. Simeone [États-Unis] ; Weiping Zou [États-Unis] ; Theodore H. Welling [États-Unis]	Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells.
002329 (2014)	Yu Zheng [Australie] ; Dennis Basel ; Shu-Oi Chow ; Colette Fong-Yee ; Sarah Kim ; Frank Buttgereit ; Colin R. Dunstan ; Hong Zhou ; Markus J. Seibel	Targeting IL-6 and RANKL signaling inhibits prostate cancer growth in bone.
003A81 (2011)	Satoru Shinriki [Japon] ; Hirofumi Jono [Japon] ; Mitsuharu Ueda [Japon] ; Kazutoshi Ota [Japon] ; Tomoko Ota [Japon] ; Takanao Sueyoshi [Japon] ; Yuichi Oike [Japon] ; Mutsuko Ibusuki [Japon] ; Akimitsu Hiraki [Japon] ; Hideki Nakayama [Japon] ; Masanori Shinohara [Japon] ; Yukio Ando [Japon]	Interleukin‐6 signalling regulates vascular endothelial growth factor‐C synthesis and lymphangiogenesis in human oral squamous cell carcinoma
004050 (2009)	Mareina Kudo [Japon] ; Hirofumi Jono [Japon] ; Satoru Shinriki [Japon] ; Shigetoshi Yano [Japon] ; Hideo Nakamura [Japon] ; Keishi Makino [Japon] ; Takuichiro Hide [Japon] ; Daisuke Muta [Japon] ; Mitsuharu Ueda [Japon] ; Kazutoshi Ota [Japon] ; Yukio Ando [Japon] ; Jun-Ichi Kuratsu [Japon]	Antitumor effect of humanized anti-interleukin-6 receptor antibody (tocilizumab) on glioma cell proliferation: Laboratory investigation

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Tumor Cells, Cultured" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Tumor Cells, Cultured" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Tumor Cells, Cultured
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021